https://www.hemlibra-hcp.com/resources/practice-forms-and-documents.html
Forms and Documents | HEMLIBRA® (emicizumab-kxwh)
Learn about the financial assistance options for people taking HEMLIBRA® (emicizumab-kxwh), including for those who don't have insurance. See full safety for...
formsdocumentsemicizumab
https://www.hemlibra.com/?cid=hea_PR_MCA9HEWBUNREG28_1&c=MCA9HEWBUNREG28
HEMLIBRA® (emicizumab-kxwh) | Hemophilia A Treatment
Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors. See full safety...
hemophilia aemicizumabtreatment
https://www.healthdirect.gov.au/medicines/medicinal-product/aht,24238/emicizumab
Emicizumab | healthdirect
More information is available on Emicizumab including side effects, age restrictions, food interactions, whether the medicine is available at a government...
emicizumabhealthdirect
https://www.hemlibra.com/patient/acerca-de-HEMLIBRA/registrese-para-obtener-ayuda.html?c=hea-16d4544d4ff.html
Regístrese para obtener ayuda | HEMLIBRA® (emicizumab-kxwh)
Regístrese para obtener ayuda y recursos por parte de un educador clínico de HEMLIBRA® (emicizumab‐kxwh). Vea toda la información de seguridad y el RECUADRO DE...
paraobtenerayudaemicizumab
https://www.hemlibra.com/patient-stories/hemlibra-stories.html
HEMLIBRA® (emicizumab-kxwh) Patient Stories
Watch videos from patients and caregivers about their experience with HEMLIBRA® (emicizumab-kxwh) treatment. See full safety and BOXED WARNING.
patient storiesemicizumab
https://www.roche.com/investors/updates/inv-update-2017-04-17
Roche announces positive interim results for emicizumab in phase III study of children with...
Roche announced today interim results from the phase III HAVEN 2 study evaluating emicizumab prophylaxis in children less than 12 years of age with haemophilia...
phase iii studyrocheannouncespositiveinterim